Literature DB >> 20605982

Development and validation of an in vivo Candida albicans biofilm denture model.

Jeniel E Nett1, Karen Marchillo, Carol A Spiegel, David R Andes.   

Abstract

The most common form of oral candidiasis, denture-associated stomatitis, involves biofilm growth on an oral prosthetic surface. Cells in this unique environment are equipped to withstand host defenses and survive antifungal therapy. Studies of the biofilm process on dentures have primarily been limited to in vitro models. We developed a rodent acrylic denture model and characterized the Candida albicans and mixed oral bacterial flora biofilm formation, architecture, and drug resistance in vivo, using time course quantitative culture experiments, confocal microscopy, scanning electron microscopy, and antifungal susceptibility assays. We also examined the utility of the model for measurement of C. albicans gene expression and tested the impact of a specific gene product (Bcr1p) on biofilm formation. Finally, we assessed the mucosal host response to the denture biofilm and found the mucosal histopathology to be consistent with that of acute human denture stomatitis, demonstrating fungal invasion and neutrophil infiltration. This current oral denture model mimics human denture stomatitis and should be useful for testing the impact of gene disruption on biofilm formation, studying the impact of anti-infectives, examining the biology of mixed Candida-oral bacterial flora biofilm infections, and characterizing the host immunologic response to this disease process.

Entities:  

Mesh:

Year:  2010        PMID: 20605982      PMCID: PMC2937450          DOI: 10.1128/IAI.00480-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

1.  Effects of modified pellicles on Candida biofilm formation on acrylic surfaces.

Authors:  H Nikawa; H Nishimura; T Hamada; H Yamashiro; L P Samaranayake
Journal:  Mycoses       Date:  1999-04       Impact factor: 4.377

Review 2.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

Review 3.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.

Authors:  Prasanna D Khot; Peter A Suci; R Lance Miller; Raoul D Nelson; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis.

Authors:  V Bissell; D H Felix; D Wray
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-07

7.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 8.  Mucosal candidiasis.

Authors:  Jose A Vazquez; Jack D Sobel
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

Review 9.  The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.

Authors:  Nathan P Wiederhold; James S Lewis
Journal:  Expert Opin Pharmacother       Date:  2007-06       Impact factor: 3.889

10.  Systemic diseases in association with microbial species in oral biofilm from elderly requiring care.

Authors:  H Senpuku; A Sogame; E Inoshita; Y Tsuha; H Miyazaki; N Hanada
Journal:  Gerontology       Date:  2003 Sep-Oct       Impact factor: 5.140

View more
  67 in total

1.  Mouse model of oropharyngeal candidiasis.

Authors:  Norma V Solis; Scott G Filler
Journal:  Nat Protoc       Date:  2012-03-08       Impact factor: 13.491

Review 2.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

4.  Candida albicans Biofilm Development and Its Genetic Control.

Authors:  Jigar V Desai; Aaron P Mitchell
Journal:  Microbiol Spectr       Date:  2015-06

5.  A recently evolved transcriptional network controls biofilm development in Candida albicans.

Authors:  Clarissa J Nobile; Emily P Fox; Jeniel E Nett; Trevor R Sorrells; Quinn M Mitrovich; Aaron D Hernday; Brian B Tuch; David R Andes; Alexander D Johnson
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

6.  Antifungal medications or disinfectants for denture stomatitis.

Authors:  Rajesh V Lalla; Anna Dongari-Bagtzoglou
Journal:  Evid Based Dent       Date:  2014-06

Review 7.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

8.  DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.

Authors:  M T Nieminen; M Hernandez; L Novak-Frazer; H Kuula; G Ramage; P Bowyer; P Warn; T Sorsa; R Rautemaa
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

Review 9.  Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.

Authors:  O Salvatori; S Puri; S Tati; M Edgerton
Journal:  J Dent Res       Date:  2016-01-08       Impact factor: 6.116

10.  Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Authors:  Eric F Kong; Christina Tsui; Heather Boyce; Ahmed Ibrahim; Stephen W Hoag; Amy J Karlsson; Timothy F Meiller; Mary Ann Jabra-Rizk
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.